Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G/A for CORCEPT THERAPEUTICS INC Common Stock (CORT).
- Disclosed ownership: 13%.
- Date of event: 31 Mar 2025.
BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for CORCEPT THERAPEUTICS INC Common Stock (CORT)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- CORT
- Shares outstanding
- 105,111,362 shares
- Disclosed Ownership
- 13,349,143 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13G/A
- Filing time
- 23 Apr 2025, 07:09:24 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 17 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 13% ownership in CORCEPT THERAPEUTICS INC Common Stock (CORT) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Apr 2025, 07:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13% | 13,349,143 | 13,197,365 | 0 | Spencer Fleming | Managing Director |